Segment 2: Molecular Targets in NSCLC

Unlock KRAS G12C for lung cancer treatment decisionsПодробнее

Lung Cancer Video Library 2020 - PATEL Emerging Molecular Targets in NSCLC KRASПодробнее

Targeting HER2, BRAF, KRAS, METПодробнее

Understanding the Molecular Targets of NSCLCПодробнее

2023 Best of Lung: Targeted Therapies in Lung CancerПодробнее

Lung Cancer Awareness part 2/5 - Molecular TestingПодробнее

Lung Cancer Video Library 2020 - BAUML - Emerging Molecular Targets in NSCLC METПодробнее

GRACEcast - Emerging Molecular Targets in NSCLC- RET Fusions with Dr. Josh BaumlПодробнее

GRACEcast - Emerging Molecular Targets in NSCLC- MET with Dr. Josh BaumlПодробнее

Lung Cancer Video Library 2020 - PATEL Emerging Molecular Targets in NSCLC EGFR Exon 20Подробнее

Best Practices in NSCLC Molecular Testing, Part IIПодробнее

GRACEcastUC-066_Lung_Dr. Lecia Sequist on Relevant Emerging Molecular Targets in Lung CancerПодробнее

Molecular drivers and therapeutic targets for neuroendocrine transformation in lung cancerПодробнее

Improving Outcomes in Molecularly Altered NSCLC Through Precision Testing and TreatmentПодробнее

Lung Cancer Video Library 2020 - BAUML - Emerging Molecular Targets in NSCLC, RET FusionsПодробнее

NSCLC: Promising Molecular TargetsПодробнее

Emerging Molecular Targets For Advanced Non Small Cell Lung Cancer NSCLCПодробнее

Molecular Testing and Actionable Targets in Lung CancerПодробнее

Segment 3: Novel Targets and Agents in Lung CancerПодробнее

Lung Cancer (Part 2) 2021Подробнее